Nanobiotix
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 weeks.
- Its last 6 Sell calls were actually followed by a +4% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is -4.7% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 0.3% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Performance
Key statistics
Price & volume
- Prev close
- 27.32
- Open
- 28.15
- Day range
- 26.12 - 28.60
- Avg price
- 26.93
- Volume
- 125.29K
- Turnover
- 3.37M
- Turnover ratei
- 0.36%
- Volume ratioi
- 1.19
- Amplitudei
- 9.08%
- 52-week rangei
- 19.14 - 57.14
Valuation
- P/Ei
- -48.36
- P/E (TTM)i
- -22.18
- P/Bi
- -36.86
- EPSi
- -0.55
- Book value / shi
- -0.72
- Net profit
- -27.92M
- Net assets
- -36.63M
Share structure
- Market cap
- 1.35B
- Float capi
- 935.17M
- Shares out
- 50.95M
- Float sharesi
- 35.29M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2020-12-11
53.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-1.55M net over the window
Short interest
- Shares short
- 170.08K
- % of floati
- 0.33%
- Days to coveri
- 1.39
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Nanobiotix (NBTX)?
Nanobiotix last traded at 26.50. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Nanobiotix's market cap?
About 1.35B.
What is the P/E ratio of Nanobiotix?
The trailing twelve-month P/E is -22.18. The Valuation tab shows it against the stock's own five-year range.
Does Nanobiotix pay a dividend?
Nanobiotix does not currently pay a regular dividend.
Is Nanobiotix a buy according to analysts?
The consensus of 2 analysts is a Buy rating, with an average 12-month price target of 64.00, which implies 141.5% upside from the current price. This is not investment advice.
What is Nanobiotix's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Nanobiotix a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.
Nanobiotix discussion 0 comments